TS
Tim Shannon
General Partner at Canaan
Westport, Connecticut
Overview
Tim Shannon is the General Partner at Canaan, with a successful track record of investing in companies like Arvinas and CytomX Therapeutics. Formerly the President and CEO of CuraGen Corporation and SVP Clinical Development at Bayer HealthCare, he brings extensive experience in the pharmaceutical and biotech sectors to his current role.
Work Experience
General Partner
2009 - Current
Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.
President and CEO
2002 - 2009
CuraGen Corporation, a biopharmaceutical development company, develops novel therapeutics for the treatment of cancer.
SVP Clinical Development
1992 - 2002